Jim Cramer on ImmunityBio: “I Would Encourage You to Own It, Provided You Don’t Own Any Other Spec”

Jim Cramer gave top insight on ImmunityBio, Inc. (NYSE:IBRX), sharing a game plan of what to buy, sell, and hold right now. When a caller mentioned that they have a small position in the stock, Cramer commented:

Okay, that is a pure spec…. I would encourage you to own it, provided you don’t own any other spec, because that company is losing a lot of money.

ImmunityBio, Inc. (NASDAQ:IBRX) develops therapies designed to strengthen the immune system against infectious diseases and several cancers. A caller asked about the stock during the March 19 episode’s lightning round, and Cramer replied:

ImmunityBio had a big cross of a huge amount of stock, but at the end, I don’t know where that stock went to. I’d like to see the stock come in and see if that block holds before I buy that, because that stock is part of the magical thinking era.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.